8-K: SOBR Safe Faces Nasdaq Delisting, Merger Fails
Notice of Delisting
SOBR Safe, Inc. will be delisted from the Nasdaq Capital Market effective September 16, 2026, following a failure to meet continued listing requirements and the anticipated termination of a merger agreement.
Summary
- SOBR Safe, Inc. received a Delisting Notice from Nasdaq, with its common stock to be delisted from the Nasdaq Capital Market at the open of trading on September 16, 2026.
- The company has been non-compliant with the minimum $1.00 bid price requirement for continued listing.
- Previous reverse stock splits (1-for-110 in Oct 2024 and 1-for-10 in Apr 2025) resulted in a cumulative 1-for-1100 split, impacting eligibility for standard compliance periods.
- The company also received an additional staff determination letter on August 21, 2026, indicating its stockholders' equity fell below the minimum $2,500,000 requirement.
- A planned merger with Clean World Ventures, Inc. (CWV) is unlikely to be consummated by the termination date of October 15, 2026, due to the need for a new Nasdaq listing application.
- Consequently, the company has decided not to appeal the equity deficiency or the delisting decision.
- The company's common stock will commence quotation on the OTC Markets under the same ticker symbol SOBR, with an application submitted for the OTCQB tier.
Sentiment
Score: 2
Explanation: StockSavvy.ai views this as a significantly negative development due to the delisting from Nasdaq and the failure to complete a crucial merger, indicating severe operational and strategic challenges.
Negatives
- The company's common stock will be delisted from the Nasdaq Capital Market.
- Failure to meet the minimum $1.00 bid price requirement for continued listing on Nasdaq.
- Failure to meet the minimum stockholders' equity requirement of $2,500,000.
- The planned merger with Clean World Ventures, Inc. is unlikely to be completed by the October 15, 2026 termination date.
- The company will no longer be listed on the Nasdaq exchange and will trade on the OTC Markets.
Risks
- Continued non-compliance with Nasdaq listing requirements, specifically the minimum bid price and stockholders' equity.
- Potential for further negative stock price performance on the OTC Markets.
- Challenges in attracting investment and maintaining liquidity on the OTC Markets compared to Nasdaq.
- The failure of the merger agreement could indicate underlying issues with the company's strategic direction or financial health.
Future Outlook
The company's common stock will commence trading on the OTC Markets, with an application submitted for the OTCQB tier. The delisting from Nasdaq and the likely failure to complete the merger suggest a challenging future outlook.
Management Comments
- The Board determined it would be in the best interest of the Company to not incur additional expense to appeal the Equity Requirement deficiency with the Hearing Panel and not request a review of the decision to delist the shares of common stock from the Nasdaq Capital Market.
Industry Context
StockSavvy.ai notes that delisting from a major exchange like Nasdaq and moving to the OTC Markets is a significant setback, often impacting a company's ability to raise capital, attract institutional investors, and maintain visibility. This move typically signals financial distress or a failure to meet stringent listing standards.
Stakeholder Impact
- Shareholders will experience a delisting from Nasdaq, potentially leading to reduced liquidity, increased volatility, and difficulty in trading shares.
- The move to OTC Markets may impact investor confidence and the ability to attract new capital.
- Creditors and suppliers may face increased uncertainty regarding the company's financial stability.
Next Steps
- Common stock to commence quotation on the OTC Markets.
- Expectation of approval for quotation on the OTCQB tier in the coming weeks.
- The company will no longer be listed on the Nasdaq Capital Market.
Key Dates
| Date | Description |
|---|---|
| 2024-10-02 | Date of a 1-for-110 reverse stock split. |
| 2025-04-04 | Date of a 1-for-10 reverse stock split. |
| 2026-03-19 | Company received a deficiency letter from Nasdaq regarding the minimum bid price requirement. |
| 2026-03-25 | Previous Form 8-K filing reporting the deficiency letter. |
| 2026-03-26 | Company filed a request for a hearing with the Nasdaq Hearings Panel. |
| 2026-04-04 | Date of a 1-for-10 reverse stock split. |
| 2026-04-24 | Company entered into an Agreement and Plan of Merger and Reorganization with Clean World Ventures, Inc. |
| 2026-04-28 | Delisting hearing held before the Nasdaq Hearings Panel. |
| 2026-04-30 | Previous Form 8-K filing reporting the merger agreement and hearing outcome. |
| 2026-05-21 | Company received a letter from the Hearings Panel granting continued listing until September 15, 2026. |
| 2026-08-14 | Company filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2026. |
| 2026-08-21 | Company received an additional staff determination letter regarding stockholders' equity deficiency. |
| 2026-08-27 | Previous Form 8-K filing reporting the additional staff determination letter. |
| 2026-09-14 | Date of the current report (Form 8-K) and the date the company received the Delisting Notice. |
| 2026-09-15 | Deadline for the company to regain compliance with Nasdaq listing requirements. |
| 2026-09-16 | Effective date of delisting from the Nasdaq Capital Market. |
| 2026-10-15 | Termination date for the Merger Agreement. |
Recommendation
sellThe delisting from Nasdaq, failure to meet listing requirements, and the likely collapse of a key merger agreement represent severe negative events. These factors indicate significant financial distress and strategic failure, making the stock a high-risk investment with a strong sell recommendation.
Keywords
Delisting, Nasdaq, OTC Markets, Merger Agreement, Listing Requirements, Bid Price, Stockholders Equity, Reverse Stock Split
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.